Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Valiquette

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Journal of Endourology|July 14, 2009
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn, Claudio Jeldres, Umberto Capitanio, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Journal of Endourology|July 14, 2009
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn, Claudio Jeldres, Umberto Capitanio, et al.
BJU International|April 13, 2007
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina, Pierre I Karakiewicz, Felix K-H Chun, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
The Journal of Urology|January 16, 2007
Development and external validation of an extended repeat biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Pageof 8